Susan Nowell

2.4k total citations
36 papers, 1.9k citations indexed

About

Susan Nowell is a scholar working on Molecular Biology, Pharmacology and Cancer Research. According to data from OpenAlex, Susan Nowell has authored 36 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Pharmacology and 9 papers in Cancer Research. Recurrent topics in Susan Nowell's work include Pharmacogenetics and Drug Metabolism (11 papers), Carcinogens and Genotoxicity Assessment (9 papers) and Glutathione Transferases and Polymorphisms (9 papers). Susan Nowell is often cited by papers focused on Pharmacogenetics and Drug Metabolism (11 papers), Carcinogens and Genotoxicity Assessment (9 papers) and Glutathione Transferases and Polymorphisms (9 papers). Susan Nowell collaborates with scholars based in United States, France and Australia. Susan Nowell's co-authors include Nicholas P. Lang, Fred F. Kadlubar, Christine B. Ambrosone, Stewart L. MacLeod, Jiyoung Ahn, Carol Sweeney, Charles N. Falany, Karen H. Dingley, Brian Coles and James S. Felton and has published in prestigious journals such as Journal of Biological Chemistry, The Science of The Total Environment and Cancer Research.

In The Last Decade

Susan Nowell

36 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan Nowell United States 24 939 576 501 422 397 36 1.9k
Candee H. Teitel United States 23 1.1k 1.2× 455 0.8× 902 1.8× 156 0.4× 348 0.9× 29 2.1k
Janeric Seidegård Sweden 26 2.0k 2.2× 695 1.2× 485 1.0× 418 1.0× 489 1.2× 73 3.0k
Adrian J. Fretland United States 22 1.1k 1.2× 437 0.8× 690 1.4× 153 0.4× 376 0.9× 52 2.1k
Nobuo Nemoto Japan 31 1.5k 1.6× 1.1k 1.9× 607 1.2× 289 0.7× 677 1.7× 118 3.2k
Lesley A. Stanley United Kingdom 23 723 0.8× 452 0.8× 303 0.6× 185 0.4× 367 0.9× 41 1.7k
Henry P. Ciolino United States 22 904 1.0× 436 0.8× 339 0.7× 226 0.5× 299 0.8× 34 2.1k
Christopher Hassett United States 19 844 0.9× 633 1.1× 335 0.7× 91 0.2× 202 0.5× 29 2.4k
Jun‐Yan Hong United States 26 1.2k 1.3× 1.1k 1.9× 457 0.9× 149 0.4× 565 1.4× 59 3.0k
George Hammons United States 23 717 0.8× 464 0.8× 316 0.6× 126 0.3× 330 0.8× 49 1.6k
T.C. Orton United Kingdom 16 633 0.7× 292 0.5× 271 0.5× 244 0.6× 274 0.7× 40 1.4k

Countries citing papers authored by Susan Nowell

Since Specialization
Citations

This map shows the geographic impact of Susan Nowell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Nowell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Nowell more than expected).

Fields of papers citing papers by Susan Nowell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Nowell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Nowell. The network helps show where Susan Nowell may publish in the future.

Co-authorship network of co-authors of Susan Nowell

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Nowell. A scholar is included among the top collaborators of Susan Nowell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Nowell. Susan Nowell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nowell, Susan & Charles N. Falany. (2006). Pharmacogenetics of human cytosolic sulfotransferases. Oncogene. 25(11). 1673–1678. 111 indexed citations
2.
Nowell, Susan, et al.. (2005). Sulfation of 4-hydroxytamoxifen is a novel pathway of tamoxifen-induced apoptosis in breast cancer cell lines. Cancer Research. 65. 1258–1259. 1 indexed citations
3.
Baker, Julie, Susan E. McCann, Mary E. Reid, et al.. (2005). Associations Between Black Tea and Coffee Consumption and Risk of Lung Cancer Among Current and Former Smokers. Nutrition and Cancer. 52(1). 15–21. 38 indexed citations
4.
Nowell, Susan, Jiyoung Ahn, James M. Rae, et al.. (2005). Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients. Breast Cancer Research and Treatment. 91(3). 249–258. 245 indexed citations
5.
Ning, Baitang, Susan Nowell, Carol Sweeney, et al.. (2005). Common genetic polymorphisms in the 5′-flanking Region of the SULT1A1 gene: haplotypes and their association with platelet enzymatic activity. Pharmacogenetics and Genomics. 15(7). 465–473. 29 indexed citations
6.
7.
Weiss, Joli, Julie Baker, Maria R. Baer, et al.. (2005). Opposing effects of aspirin and acetaminophen use on risk of adult acute leukemia. Leukemia Research. 30(2). 164–169. 22 indexed citations
8.
Ahn, Jiyoung, Marilie D. Gammon, Regina M. Santella, et al.. (2005). Associations between Breast Cancer Risk and the Catalase Genotype, Fruit and Vegetable Consumption, and Supplement Use. American Journal of Epidemiology. 162(10). 943–952. 111 indexed citations
9.
Nowell, Susan, Jiyoung Ahn, & Christine B. Ambrosone. (2004). Gene-Nutrient Interactions in Cancer Etiology. Nutrition Reviews. 62(11). 427–438. 27 indexed citations
10.
Ning, Baitang, Charles Wang, Fabrice Morel, et al.. (2003). Human glutathione S-transferase A2 polymorphisms. Pharmacogenetics. 14(1). 35–44. 41 indexed citations
11.
Sweeney, Carol, Brian Coles, Susan Nowell, Nicholas P. Lang, & Fred F. Kadlubar. (2002). Novel markers of susceptibility to carcinogens in diet: associations with colorectal cancer. Toxicology. 181-182. 83–87. 38 indexed citations
12.
Wong, P., et al.. (2001). Validity of an ELISA for N-acetyltransferase-2 (NAT2) phenotyping. Journal of Immunological Methods. 251(1-2). 1–9. 4 indexed citations
13.
14.
Nowell, Susan, Christine B. Ambrosone, Stewart L. MacLeod, et al.. (2000). Relationship of phenol sulfotransferase activity (SULT1A1) genotype to sulfotransferase phenotype in platelet cytosol. Pharmacogenetics. 10(9). 789–797. 70 indexed citations
15.
Dickerson, R., et al.. (1999). Modulation of endocrine pathways by 4,4′-DDE in the deer mouse Peromyscus maniculatus. The Science of The Total Environment. 233(1-3). 97–108. 15 indexed citations
16.
Lang, Nicholas P., Susan Nowell, Michael Malfatti, et al.. (1999). In vivo human metabolism of [2-14C]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Cancer Letters. 143(2). 135–138. 21 indexed citations
17.
Malfatti, Michael, Kristen S. Kulp, Mark G. Knize, et al.. (1999). The identification of [2-14C]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine metabolites in humans. Carcinogenesis. 20(4). 705–713. 86 indexed citations
18.
Nowell, Susan, et al.. (1998). Identification of Enzymes Responsible for the Metabolism of Heme in Human Platelets. Journal of Biological Chemistry. 273(50). 33342–33346. 28 indexed citations
19.
Radominska, A, Richard R. Drake, Xiaoyi Zhu, et al.. (1996). Photoaffinity Labeling of Human Recombinant Sulfotransferases with 2-Azidoadenosine 3′,5′-[5′-32P]Bisphosphate. Journal of Biological Chemistry. 271(6). 3195–3199. 4 indexed citations
20.
Battaglia, Eric, Susan Nowell, Carl L. Berg, et al.. (1996). Two kinetically-distinct components of UDP-glucuronic acid transport in rat liver endoplasmic reticulum. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1283(2). 223–231. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Candee H. Teitel Breakdown of academic impact, for papers by Janeric Seidegård Breakdown of academic impact, for papers by Adrian J. Fretland Breakdown of academic impact, for papers by Nobuo Nemoto Breakdown of academic impact, for papers by Lesley A. Stanley Breakdown of academic impact, for papers by Henry P. Ciolino Breakdown of academic impact, for papers by Christopher Hassett Breakdown of academic impact, for papers by Jun‐Yan Hong Breakdown of academic impact, for papers by George Hammons Breakdown of academic impact, for papers by T.C. Orton
Rankless by CCL
2026